Variables | n/Mean | %/SD | |
---|---|---|---|
Age (years) | 66.21 | 11.91 | |
Sex | Male | 17 | 32.1 |
Female | 36 | 67.9 | |
MR severity | Moderate | 14 | 26.4 |
Severe | 39 | 73.6 | |
TR severity | No TR | 2 | 3.8 |
Mild | 16 | 30.2 | |
Mild to moderate | 10 | 18.9 | |
Moderate | 13 | 24.5 | |
Moderate to severe | 3 | 5.7 | |
Severe | 9 | 17 | |
AR severity | No TR | 10 | 18.9 |
Mild | 23 | 43.4 | |
Mild to moderate | 5 | 9.4 | |
Moderate | 5 | 9.4 | |
Moderate to severe | 1 | 1.9 | |
Severe | 2 | 3.8 | |
MR pathology | Primary | 26 | 49.1 |
Functional | 19 | 35.8 | |
Combined | 8 | 15.1 | |
LVEF (%) | 41.67 | 13.0 | |
LVEDD (mm) | 50.9 | 7.6 | |
LVESD (mm) | 36.2 | 8.3 | |
LAV (ml/m2) | 71.21 | 32.70 | |
MRVC (mm) | 6.27 | 2.17 | |
VC area using MPR (cm2) | 0.65 | 0.33 | |
RAA (cm2) | 19.28 | 7.05 | |
RVDD (mm) | 36.54 | 5.74 | |
RVSP (mmHg) | 49.73 | 17.23 | |
TAPSE (mm) | 18.55 | 3.34 | |
VC area using 3D echo (cm2) | 0.63 | 0.32 |